Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Result of General Meeting

17 Feb 2017 10:40

RNS Number : 1911X
Cello Group plc
17 February 2017
 

Cello Group plc

 

Result of General Meeting

 

Cello Group plc (AIM: CLL; "Cello", the "Group" or the "Company"), the healthcare focused strategic marketing group, is pleased to announce that at its General Meeting held earlier today, all resolutions in connection with the conditional placing of 10,309,279 new ordinary shares of 10 pence each in the Company ("Ordinary Shares"), as announced by the Company on 1 February 2017, were duly passed. Admission of the new Ordinary Shares is expected on 20 February 2017.

 

17 February 2017

 

This announcement contains inside information.

 

Enquiries:

 

Cello Group

020 7812 8460

Mark Scott, Chief Executive

Mark Bentley, Group Finance Director

Cenkos Securities

0207 397 8900

Bobbie Hilliam / Harry Pardoe - NOMAD

Julian Morse / Michael Johnson - Sales

Buchanan

020 7466 5000

Richard Oldworth

Jamie Hooper

Madeleine Seacombe

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROMTRMMTMBJBBRR

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.